CDK 4/6 inhibitors

Pfizer PBC 125 Pill - tan capsule-shape

Generic Name: palbociclib

Pill with imprint Pfizer PBC 125 is Tan, Capsule-shape and has been identified as Ibrance 125 mg. It is supplied by Pfizer Inc.

Ibrance is used in the treatment of Breast Cancer, Metastatic; Breast Cancer; Liposarcoma; Breast Cancer, Male and belongs to the drug class CDK 4/6 inhibitors. Ibrance 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Ibrance (Palbociclib [ pal-boe-sye-klib ])-Pfizer PBC 125-125 mg-Tan-Capsule-shape

Ibrance
Generic Name: palbociclib [ pal-boe-sye-klib ]
Imprint: Pfizer PBC 125
Strength: 125 mg
Color: Tan
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: CDK 4/6 inhibitors
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00069-0189
Inactive Ingredients: Microcrystalline cellulose, Lactose monohydrate, Sodium starch glycolate type A potato, Silicon dioxide, Magnesium stearate, Ferric oxide red, Ferric oxide yellow, Titanium dioxide, Shellac, Ammonia, Propylene glycol, Dimethicone,
Latest News
Related Drugs